World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
93
Citations
27725
World Ranking
2131
National Ranking
1153

Medicine

D-Index
93
Citations
28104
World Ranking
10984
National Ranking
5648

Terry J. Smith publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Terry J. Smith sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 468 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Terry J. Smith D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Terry J. Smith sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 93 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Terry J. Smith is affiliated with the University of Michigan-Ann Arbor in the United States and has an extensive record of research publications primarily in the field of medicine, with a strong focus on pathology, endocrinology, ophthalmology, and neurology.

Their publication record includes work across diverse subfields, such as:

  • Pathology and Forensic Medicine
  • Endocrinology, Diabetes and Metabolism
  • Ophthalmology
  • Neurology
  • Rheumatology

The main topics Terry J. Smith has covered in their research include:

  • Ophthalmology and Eye Disorders
  • Glaucoma and retinal disorders
  • Thyroid Disorders and Treatments
  • Pituitary Gland Disorders and Treatments
  • Multiple Sclerosis Research Studies
  • Cerebral Venous Sinus Thrombosis
  • Peripheral Neuropathies and Disorders

The frequent venues for Terry J. Smith's publications indicate a consistent contribution to endocrinology and neurology-related journals, including:

  • Journal of the Endocrine Society
  • The Journal of Clinical Endocrinology & Metabolism
  • Neurology
  • Neurology Neuroimmunology & Neuroinflammation
  • Endocrine Practice

Among the recent research papers associated with the broader scientific context of their work, the following have been notable:

  • "Teprotumumab for the Treatment of Active Thyroid Eye Disease" (2020), New England Journal of Medicine
  • "Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials" (2021), The Lancet Diabetes & Endocrinology
  • "Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment" (2021), Ophthalmology
  • "2021 update on thyroid-associated ophthalmopathy" (2021), Journal of Endocrinological Investigation
  • "Retinal Optical Coherence Tomography in Neuromyelitis Optica" (2021), Neurology Neuroimmunology & Neuroinflammation

Terry J. Smith has collaborated frequently with several researchers, indicating an active involvement in multi-author studies and interdisciplinary projects. Their top coauthors include:

  • Michael R. Yeaman
  • Lawrence J. Cook
  • Robert J. Holt
  • Friedemann Paul
  • Terrence F. Blaschke

Their research output spans over 200 publications in the broad field of medicine, demonstrating a sustained engagement with clinical and biomedical research.

Best Publications

  • Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation.

    R. S. Smith;T. J. Smith;T. M. Blieden;R. P. Phipps

  • Current Perspective on the Pathogenesis of Graves’ Disease and Ophthalmopathy

    Bellur S. Prabhakar;Rebecca S. Bahn;Terry J. Smith;Terry J. Smith

  • Teprotumumab for Thyroid-Associated Ophthalmopathy

    Terry J. Smith;George J. Kahaly;Daniel G. Ezra;James C. Fleming

  • Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry.

    Melvin B. Heyman;Barbara S. Kirschner;Benjamin D. Gold;George Ferry

  • Teprotumumab for the Treatment of Active Thyroid Eye Disease

    Raymond S. Douglas;George J. Kahaly;Amy Patel;Saba Sile

  • An update of recent evidence of the relationship between objective and self-report measures of the physical environment and physical activity behaviours

    Gavin Mccormack;Billie Giles-Corti;Andrea Lange;T. Smith

  • Teprotumumab for the treatment of active thyroid eye disease

    Douglas Rs;Kahaly Gj;Patel A;Sile S

  • Evidence for an Association between Thyroid-Stimulating Hormone and Insulin-Like Growth Factor 1 Receptors: A Tale of Two Antigens Implicated in Graves’ Disease

    Shanli Tsui;Vibha Naik;Neil Hoa;Catherine J. Hwang

  • Connective tissue, glycosaminoglycans, and diseases of the thyroid.

    Terry J. Smith;Rebecca S. Bahn;Colum A. Gorman

  • Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway.

    Jane Pritchard;Rui Han;Noah Horst;William W. Cruikshank

  • Thy-1 Expression in Human Fibroblast Subsets Defines Myofibroblastic or Lipofibroblastic Phenotypes

    Laura Koumas;Terry J. Smith;Steven Feldon;Neil Blumberg

  • Relationship Between Reported and Measured Sleep Times: The Sleep Heart Health Study (SHHS)

    Graciela E. Silva;James L. Goodwin;Duane L. Sherrill;Jean L. Arnold

  • Insulin-Like Growth Factor-I Regulation of Immune Function: A Potential Therapeutic Target in Autoimmune Diseases?

    Terry J. Smith

  • Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor.

    Terry J. Smith;Neil Hoa

  • Orbital Fibroblast Heterogeneity May Determine the Clinical Presentation of Thyroid-Associated Ophthalmopathy

    Terry J. Smith;Laura Koumas;AnneMarie Gagnon;Andrea Bell

  • Activation of Human Orbital Fibroblasts through CD40 Engagement Results in a Dramatic Induction of Hyaluronan Synthesis and Prostaglandin Endoperoxide H Synthase-2 Expression INSIGHTS INTO POTENTIAL PATHOGENIC MECHANISMS OF THYROID-ASSOCIATED OPHTHALMOPATHY

    H. James Cao;Hwai Shi Wang;Ying Zhang;Hung Yun Lin

  • Inhibitory effect of leptin on human uterine contractility in vitro

    Audrey T. Moynihan;Audrey T. Moynihan;Mark P. Hehir;Siobhan V. Glavey;Terry J. Smith

  • Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.

    Yao Wang;Terry J. Smith

  • Evidence of adipocyte differentiation in human orbital fibroblasts in primary culture.

    A Sorisky;D Pardasani;A Gagnon;T J Smith

  • Igs from Patients with Graves’ Disease Induce the Expression of T Cell Chemoattractants in Their Fibroblasts

    Jane Pritchard;Noah Horst;William Cruikshank;Terry J. Smith

Frequent Co-Authors

Richard P. Phipps
Richard P. Phipps University of Rochester
Kay E. Davies
Kay E. Davies University of Oxford
Michael R. Yeaman
Michael R. Yeaman University of California, Los Angeles
Martin Cormican
Martin Cormican University of Galway
Friedemann Paul
Friedemann Paul Charité - University Medicine Berlin
William W. Cruikshank
William W. Cruikshank Boston University
Laszlo Hegedüs
Laszlo Hegedüs Odense University Hospital
Stuart F. Quan
Stuart F. Quan Brigham and Women's Hospital
Jens Ducrée
Jens Ducrée Dublin City University
George J. Kahaly
George J. Kahaly Johannes Gutenberg University of Mainz

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

A background in Biology or Biochemistry opens doors to diverse online degrees and career options in healthcare and life sciences. For those interested in leadership, an online healthcare MBA blends science knowledge with business and management training, preparing graduates for administration or management roles in hospitals, clinics, and biotech companies.

Another promising direction is health information and coding careers. Professionals can pursue different certifications, such as CPC and CCS. To understand which pathway to choose, review the credentials, costs, and salary expectations for cpc vs ccs certification. Each comes with unique benefits depending on your career goals.

Graduates interested in behind-the-scenes healthcare roles should also explore medical coding salary trends and training requirements. Medical coding and billing continue to see solid employment growth due to expanding healthcare needs. Considering the evolving job landscape, it’s important to weigh the medical coding job outlook—including the flexibility, job stability, and day-to-day work expectations.

Best Scientists Citing Terry J. Smith

Trending Scientists

Recently Published Articles